CSBR:NASDAQ
Champions Oncology Inc
$4.84
arrow_upward
+1.04%(+0.050) 1D
Nov 9, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.94
High
$4.94
Low
$4.84
Mkt. cap
67.37M
Avg. vol.
9.27K
Volume
0.00
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.94
High
$4.94
Low
$4.84
Mkt. cap
67.37M
Avg. vol.
9.27K
Volume
0.00
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
The Motley Fool
·
31 minutes ago
Stock Market Sell-Off: Meet the Unstoppable Vanguard ETF Obliterating the S&P 500 in 2026
Benzinga
·
36 minutes ago
Stock Market Today: Dow, S&P 500 Futures Rise, Nasdaq 100 Futures Fall as Trump Signals Iran War to End
The Motley Fool
·
1 hour ago
2 Vanguard Index Funds to Buy Now to Beat the S&P 500 in the Next Year, According to Wall Street
FXStreet
·
1 hour ago
S&P 500: Tech rebound drives strong gains – Deutsche Bank
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com